Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Calvert

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Seminars in Oncology|December 22, 1999
Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell linesP G Smith, E Marshman, A H Calvert, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2001
A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancerD W Miles, I E Smith, R E Coleman, et al.
British Journal of Cancer|February 1, 1993
Phase I trial with pharmacokinetics of CB10-277 given by 24 hours continuous infusionB J Foster, D R Newell, L A Gumbrell, et al.
Cancer Treatment Reviews|September 1, 1985
Phase I studies with carboplatin at the Royal Marsden HospitalA H Calvert, S J Harland, D R Newell, et al.
British Journal of Cancer|February 24, 2001
Estimation of glomerular filtration rate in cancer patientsJ G Wright, A V Boddy, M Highley, et al.
British Journal of Cancer|November 1, 1989
Cisplatin/carboplatin cross-resistance in ovarian cancerM E Gore, I Fryatt, E Wiltshaw, et al.
British Medical Journal|July 5, 1975
Kinetically-based multiple drug treatment for advanced head and neck cancerL A Price, B T Hill, A H Calvert, et al.
European Journal of Cancer|December 1, 1980
The intracellular mechanism of action of metoprine (DDMP)G P Browman, A H Calvert, G A Taylor, et al.
Cancer Chemotherapy and Pharmacology|February 7, 2001
Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumoursH D Thomas, M J Lind, J Ford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Clinical pharmacokinetics of the antipurine antifolate (6R)-5,10- dideaza-5,6,7,8-tetrahydrofolic acid (Lometrexol) administered with an oral folic acid supplementS R Wedge, S Laohavinij, G A Taylor, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Seminars in Oncology|December 22, 1999
Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell linesP G Smith, E Marshman, A H Calvert, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2001
A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancerD W Miles, I E Smith, R E Coleman, et al.
British Journal of Cancer|February 1, 1993
Phase I trial with pharmacokinetics of CB10-277 given by 24 hours continuous infusionB J Foster, D R Newell, L A Gumbrell, et al.
Cancer Treatment Reviews|September 1, 1985
Phase I studies with carboplatin at the Royal Marsden HospitalA H Calvert, S J Harland, D R Newell, et al.
British Journal of Cancer|February 24, 2001
Estimation of glomerular filtration rate in cancer patientsJ G Wright, A V Boddy, M Highley, et al.
British Journal of Cancer|November 1, 1989
Cisplatin/carboplatin cross-resistance in ovarian cancerM E Gore, I Fryatt, E Wiltshaw, et al.
British Medical Journal|July 5, 1975
Kinetically-based multiple drug treatment for advanced head and neck cancerL A Price, B T Hill, A H Calvert, et al.
European Journal of Cancer|December 1, 1980
The intracellular mechanism of action of metoprine (DDMP)G P Browman, A H Calvert, G A Taylor, et al.
Cancer Chemotherapy and Pharmacology|February 7, 2001
Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumoursH D Thomas, M J Lind, J Ford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Clinical pharmacokinetics of the antipurine antifolate (6R)-5,10- dideaza-5,6,7,8-tetrahydrofolic acid (Lometrexol) administered with an oral folic acid supplementS R Wedge, S Laohavinij, G A Taylor, et al.
Pageof 15